Handheld Adipose Stem Cell Processor for Point of Care Application

Award Information
Agency:
Department of Defense
Branch:
Army
Amount:
$99,799.00
Award Year:
2014
Program:
SBIR
Phase:
Phase I
Contract:
W81XWH-14-C-0019
Agency Tracking Number:
A132-087-0015
Solicitation Year:
2013
Solicitation Topic Code:
A13-087
Solicitation Number:
2013.2
Small Business Information
Tissue Genesis, Inc
677 Ala Moana Blvd Suite 1100, Honolulu, HI, 96813
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
000000000
Principal Investigator
 Rolf Wolters
 Director of Product Management
 (808) 772-5585
 rwolters@tissuegenesis.com
Business Contact
 Tom Cannon
Title: Executive Vice President
Phone: (808) 539-9331
Email: tcannon@tissuegenesis.com
Research Institution
N/A
Abstract
Tissue Genesis (TGI) is proposing to develop a highly portable, easy to use, low-cost, point-of-care, adipose-derived stem cell (ASC) isolation device that fully integrates the process from fat extraction to cell product. This next generation system addresses current technology limitations including: sterility breaks, acquisition and process time, complexity of operation, and cost. The convenient and rapid recovery of millions of regenerative cells will fill the unmet need as a readily available source of adult stem cells for therapeutic use across multiple military trauma needs, such as wound healing, tissue and nerve repair, orthopedic injury repair, plastics and aesthetics, ophthalmology, and otolaryngology. The proposed system addresses current technology, cost, and convenience shortfalls and allows for a rapid translation of regenerative stem cell therapeutics into the clinic.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government